Navigation Links
Egenix, Inc. Appoints Dr. Daniel Petrylak Chairman of Scientific Advisory Board
Date:4/8/2008

MILLBROOK, N.Y., April 8, 2008 /PRNewswire/ -- Donald C. Fresne, Chairman and CEO, Egenix, Inc., announced the appointment of Daniel Petrylak, MD as Chairman of the company's scientific advisory board. Dr. Petrylak is currently Associate Professor of Medicine at Columbia University Medical Center where he is Director of Genitourinary Oncology, Division of Medical Oncology. He is the co-author of numerous peer reviewed scientific papers and is a national leader in the treatment of cancers of prostate, kidney, and bladder. Dr. Petrylak stated, "I enthusiastically look forward to working with the Egenix team. I believe the company's initiatives for development of targeted translation inhibitors will reach the clinic in a timely fashion and provide unique benefits for patients with cancer."

About Egenix, Inc.

Based in Millbrook, New York, Egenix, Inc. is a privately held biotechnology company responding to the demand for more effective cancer therapies. Egenix is developing small molecule inhibitors of translation initiation, a new paradigm in target-specific, non-cytotoxic anti-cancer therapy, and the use of translation initiation-specific biomarkers to assess tumor sensitivity to anti-cancer therapy with this novel class of anti-cancer drugs.


'/>"/>
SOURCE Egenix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. NanoLogix Inc. Provides Financial Update, Appoints Bert Pharis as New Director
2. Observant LLC Appoints Two New Directors to the Senior Management Team
3. Immune Tolerance Institute Appoints Aaron B. Kantor Ph.D. Chief Scientific Officer
4. Light Sciences Oncology Appoints David P. Holveck to Its Board of Directors
5. IDM Pharma Appoints Gregory J. Tibbitts to Board of Directors
6. Caliper Life Sciences Appoints Peter F. McAree Senior Vice President and Chief Financial Officer
7. PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business
8. Touch Bionics appoints Head of Clinical Advocacy
9. Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team
10. Neurobiological Technologies Appoints Matthew M. Loar as Chief Financial Officer
11. NxStage Appoints Tom Shea as Senior Vice President of Manufacturing Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, doctors ... being treated for breast cancer benefitted from an injection of stem cells derived from ... frequent side effect of cancer treatment. , Lymphedema refers to the swelling ...
(Date:6/23/2016)... -- Andrew D Zelenetz , ... Published recently in Oncology & ... Andrew D Zelenetz , discusses the fact ... placing an increasing burden on healthcare systems worldwide, ... the patents on many biologics expiring, interest in ...
(Date:6/23/2016)... ... 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), a ... webinar on Performing Quality Investigations: Getting to Root Cause. This ... charge. , Incomplete investigations are still a major concern to the Regulatory Authorities ...
Breaking Biology Technology:
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/16/2016)... May 16, 2016   EyeLock LLC , a ... the opening of an IoT Center of Excellence in ... expand the development of embedded iris biometric applications. ... of convenience and security with unmatched biometric accuracy, making ... aside from DNA. EyeLock,s platform uses video technology to ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
Breaking Biology News(10 mins):